18-Aug-2026 - The Globe and Mail Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s shares closed yesterday at $515.55. Unlock powerful ...
12-Aug-2026 - The Globe and Mail Bernstein Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX) Bernstein analyst William Pickering maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $608.00. Unlock powerful investing tools with TipRanks Premium to make smarter, ...
12-Aug-2026 - The Globe and Mail Scotiabank Remains a Buy on Vertex Pharmaceuticals (VRTX) Scotiabank analyst Louise Chen maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $558.00. Unlock powerful investing tools with TipRanks Premium to make smarter, more ...
18-Aug-2026 - The Globe and Mail Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s shares closed yesterday at $515.55. Unlock powerful ...
12-Aug-2026 - The Globe and Mail Bernstein Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX) Bernstein analyst William Pickering maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $608.00. Unlock powerful investing tools with TipRanks Premium to make smarter, ...
12-Aug-2026 - The Globe and Mail Scotiabank Remains a Buy on Vertex Pharmaceuticals (VRTX) Scotiabank analyst Louise Chen maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $558.00. Unlock powerful investing tools with TipRanks Premium to make smarter, more ...
